Direct antiviral agents and risk of HCC: Waiting for Godot
- PMID: 29024699
- DOI: 10.1016/j.jhep.2017.08.039
Direct antiviral agents and risk of HCC: Waiting for Godot
Comment in
-
Reply to: "Direct antiviral agents and risk of HCC: Waiting for Godot".J Hepatol. 2018 Mar;68(3):616-617. doi: 10.1016/j.jhep.2017.10.002. Epub 2017 Oct 9. J Hepatol. 2018. PMID: 29024697 No abstract available.
Comment on
-
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.J Hepatol. 2017 Dec;67(6):1204-1212. doi: 10.1016/j.jhep.2017.07.025. Epub 2017 Aug 9. J Hepatol. 2017. PMID: 28802876
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
